FDA Inspection
Main Line Fertility Clinic P.C.Main Line Fertility Clinic P.C. – FDA Inspection, Apr 8, 2019
Record Details
This FDA Inspection record concerns Main Line Fertility Clinic P.C., with an inspection on April 8, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c4e90a29-349b-40f4-9e4e-33504c561748
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085521
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.55(c)Name and personal info on accompanying records
- 21 CFR 1271.55(b)(1)Statement re: certified testing lab
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Main Line Fertility Clinic P.C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 19, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 8, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 24, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Main Line Fertility Clinic P.C.
- FDA Inspection 1220397 - 2023-09-14
- FDA Inspection 989118 - 2016-10-19
- FDA Inspection 830799 - 2013-05-08
- FDA Inspection 734330 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.